*nlm.life
			PubMed Journals: Emerg Infect Dis

  Source:		PMID: 15030704
  Download:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322919/pdf/03-0482.pdf

    		Emerg Infect Dis. 2004 Feb;10(2):317-9.
     
			Interferon-beta 1a and SARS coronavirus
			replication.

			Hensley LE(1), Fritz LE, Jahrling PB, Karp
			CL, Huggins JW, Geisbert TW.

			Author Information
			(1) Virology Division, US Army Medical Research
			Institute of Infectious Diseases, Fort Detrick,
			Maryland 21702, USA.

			A global outbreak of severe acute respiratory syndrome
			(SARS) caused by a novel coronavirus
			began in March 2003. The rapid emergence
			of SARS and the substantial illness and
			death it caused have made it a critical
			public health issue. Because no effective
			treatments are available, an intensive effort
			is under way to identify and test promising
			antiviral drugs. Here, we report that recombinant
			human interferon-beta 1a potently inhibits
			SARS coronavirus replication in vitro.

			DOI: 10.3201/eid1002.030482 PMCID: PMC3322919
			PMID: 15030704 [Indexed for MEDLINE]

     			                         Tweet       Print